What is the PERMIT project? Which PERMIT recommendations are most relevant for patients? Why are these important? All of these questions are addressed in this short leaflet, developed in collaboration with the European Patients' Forum (EPF).
LAY SUMMARY - TRANSLATIONAL METHODS
The translational stage is essential in the personalised medicine research pipeline. A review of the existing literature was conducted to map the methods that are currently used during this stage and to identify the main gaps and challenges that could be addressed with targeted recommendations.
LAY SUMMARY - CLINICAL TRIALS IN PERSONALISED MEDICINE
Evaluating therapeutic solutions through clinical trials is essential, before integrating them into routine care. A review of the literature on the methods and clinical trial designs used in personalised medicine was conducted to better understand the most commonly used designs and to identify gaps and challenges that could be addressed with targeted recommendations.